Found: 1

Select item for more details and to access through your institution.

  • A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy.

    Published in:
    Science Translational Medicine, 2023, v. 15, n. 691, p. 1, doi. 10.1126/scitranslmed.abq2915
    By:
    • Eteläinen, Tony S.;
    • Silva, M. Catarina;
    • Uhari-Väänänen, Johanna K.;
    • De Lorenzo, Francesca;
    • Jäntti, Maria H.;
    • Cui, Hengjing;
    • Chavero-Pieres, Marta;
    • Kilpeläinen, Tommi;
    • Mechtler, Christina;
    • Svarcbahs, Reinis;
    • Seppälä, Erin;
    • Savinainen, Juha R.;
    • Puris, Elena;
    • Fricker, Gert;
    • Gynther, Mikko;
    • Julku, Ulrika H.;
    • Huttunen, Henri J.;
    • Haggarty, Stephen J.;
    • Myöhänen, Timo T.
    Publication type:
    Article